hospital cardiac arrest
Recently Published Documents





2022 ◽  
Vol 9 ◽  
pp. 100196
Wachiranun Sirikul ◽  
Chanodom Piankusol ◽  
Borwon Wittayachamnankul ◽  
Sattha Riyapan ◽  
Jirapong Supasaovapak ◽  

2022 ◽  
Vol 68 ◽  
pp. 22-30
M. Schluep ◽  
H. Endeman ◽  
B.Y. Gravesteijn ◽  
C. Kuijs ◽  
M.J. Blans ◽  

2022 ◽  
Vol 38 ◽  
pp. 100937
Rupak Desai ◽  
Akhil Jain ◽  
Kartik Dhaduk ◽  
Arashpreet Kaur Chhina ◽  
Jilmil Raina ◽  

2022 ◽  
Vol 38 ◽  
pp. 100934
Ryan Gouveia e Melo ◽  
Carolina Machado ◽  
Daniel Caldeira ◽  
Mariana Alves ◽  
Alice Lopes ◽  

SungJoon Park ◽  
Sung Woo Lee ◽  
Kap Su Han ◽  
Eui Jung Lee ◽  
Dong-Hyun Jang ◽  

Abstract Background A favorable neurological outcome is closely related to patient characteristics and total cardiopulmonary resuscitation (CPR) duration. The total CPR duration consists of pre-hospital and in-hospital durations. To date, consensus is lacking on the optimal total CPR duration. Therefore, this study aimed to determine the upper limit of total CPR duration, the optimal cut-off time at the pre-hospital level, and the time to switch from conventional CPR to alternative CPR such as extracorporeal CPR. Methods We conducted a retrospective observational study using prospective, multi-center registry of out-of-hospital cardiac arrest (OHCA) patients between October 2015 and June 2019. Emergency medical service–assessed adult patients (aged ≥ 18 years) with non-traumatic OHCA were included. The primary endpoint was a favorable neurological outcome at hospital discharge. Results Among 7914 patients with OHCA, 577 had favorable neurological outcomes. The optimal cut-off for pre-hospital CPR duration in patients with OHCA was 12 min regardless of the initial rhythm. The optimal cut-offs for total CPR duration that transitioned from conventional CPR to an alternative CPR method were 25 and 21 min in patients with initial shockable and non-shockable rhythms, respectively. In the two groups, the upper limits of total CPR duration for achieving a probability of favorable neurological outcomes < 1% were 55–62 and 24–34 min, respectively, while those for a cumulative proportion of favorable neurological outcome > 99% were 43–53 and 45–71 min, respectively. Conclusions Herein, we identified the optimal cut-off time for transitioning from pre-hospital to in-hospital settings and from conventional CPR to alternative resuscitation. Although there is an upper limit of CPR duration, favorable neurological outcomes can be expected according to each patient’s resuscitation-related factors, despite prolonged CPR duration.

2022 ◽  
Asad Ali Usman ◽  
Samantha Stein ◽  
Audrey Spelde ◽  
Felipe Teran-merino ◽  
John Augoustides ◽  

Abstract This trial is aimed at studying the utility and interventional outcomes of rescue transesophageal echocardiography (RescueTEE) to aid in diagnosis, change in management, and outcomes during CPR by using a point of care RescueTEE protocol in the evaluation of in-hospital cardiac arrest (IHCA). This is an interventional prospective convenience sampled partially blinded phase II clinical trial with primary outcomes of survival to hospital discharge (SHD) with RescueTEE image guided ACLS versus conventional ACLS.

2022 ◽  
Vol 11 (2) ◽  
pp. 403
Shu-Hsien Hsu ◽  
Po-Hsuan Kao ◽  
Tsung-Chien Lu ◽  
Chih-Hung Wang ◽  
Cheng-Chung Fang ◽  

Objectives: Early recognition and prevention of in-hospital cardiac arrest (IHCA) play an increasingly important role in the Chain of Survival. However, clinical tools for predicting IHCA in the emergency department (ED) are scanty. We sought to evaluate the role of serum lactate in predicting ED-based IHCA. Methods: Data were retrieved from 733,398 ED visits over a 7-year period in a tertiary medical centre. We selected one ED visit per person and excluded out-of-hospital cardiac arrest, children, or those without lactate measurements. Patient demographics, computerised triage information, and serum lactate levels were extracted. The initial serum lactate levels were grouped into normal (≤2 mmol/L), moderately elevated (2 < lactate ≤ 4), and highly elevated (>4 mmol/L) categories. The primary outcome was ED-based IHCA. Results: A total of 17,392 adult patients were included. Of them, 342 (2%) developed IHCA. About 50% of the lactate levels were normal, 30% were moderately elevated, and 20% were highly elevated. In multivariable analysis, the group with highly elevated lactate had an 18-fold increased risk of IHCA (adjusted odds ratio [OR], 18.0; 95% confidence interval [CI], 11.5–28.2), compared with the normal lactate group. In subgroup analysis, the poor lactate-clearance group (<2.5%/h) was associated with a 7.5-fold higher risk of IHCA (adjusted OR, 7.5; 95%CI, 3.7–15.1) compared with the normal clearance group. Conclusions: Elevated lactate levels and poor lactate clearance were strongly associated with a higher risk of ED-based IHCA. Clinicians may consider a more liberal sampling of lactate in patients at higher risk of IHCA with follow-up of abnormal levels.

Talip E. Eroglu ◽  
Carlo A. Barcella ◽  
Thomas A. Gerds ◽  
Lars Vedel Kessing ◽  
Nertila Zylyftari ◽  

Sign in / Sign up

Export Citation Format

Share Document